Belgium
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
24.30%
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
18.45%
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
|
3 |
11.32%
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
4 |
11.09%
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
5 |
2.92%
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
The Biotechnology company in Belgium with the highest EBITDA Margin is UCB SA (Brussels Stock Exchange: UCB.BR) at 24.30%.
The Biotechnology company in Belgium with the lowest EBITDA Margin is Ion Beam Applications SA (Brussels Stock Exchange: IBAB.BR) at 2.92%.
The top 10 Biotechnology companies in Belgium by EBITDA Margin are UCB SA, Galapagos NV, Azelis Group NV, Tessenderlo Group NV and Ion Beam Applications SA.
The bottom 10 Biotechnology companies in Belgium by EBITDA Margin are Ion Beam Applications SA, Tessenderlo Group NV, Azelis Group NV, Galapagos NV and UCB SA.